Skip to main navigation Skip to search Skip to main content

Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer

  • Anne-Marie Cleton-Jansen
  • , Horst Buerger
  • , Natalja ter Haar
  • , Katja Philippo
  • , Marc J. van de Vijver
  • , Werner Boecker
  • , Vincent T. H. B. M. Smit
  • , Cees J. Cornelisse

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Loss of heterozygosity (LOH) at the long arm of chromosome 16 is a frequent genetic alteration in breast cancer. It can occur by physical loss of part of or the entire chromosomal arm, resulting in a decrease in copy number or loss followed by mitotic recombination. Comparative genomic hybridization (CGH) demonstrated that well-differentiated breast tumors showed significantly more physical loss of 16q than did poorly differentiated ones and that this difference was already discernable in the preinvasive stage. However, polymorphic markers detected no difference in the frequency of 16q LOH between invasive tumors of different histological grade. Here, by combining data on LOH (n=52), fluorescence in situ hybridization (n=18) with chromosome 16-specific probes, and CGH (n=34), we show a preference in well-differentiated grade I tumors for physical loss of chromosome arm 16q, whereas in poorly differentiated grade III tumors LOH is accompanied by mitotic recombination. This clarifies the discrepancies observed between CGH and LOH for 16q in breast cancer. These different somatic genetic mechanisms may reflect the presence of multiple tumor suppressor genes that are the target of LOH at chromosome arm 16q
Original languageEnglish
Pages (from-to)109-116
JournalGenes, chromosomes & cancer
Volume41
Issue number2
DOIs
Publication statusPublished - 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer'. Together they form a unique fingerprint.

Cite this